Back
Protagonist Therapeutics Stock Price Chart
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.
Buy
53
PTGX
Protagonist Therapeutics
Last Price:
$56.38
Seasonality Move:
17.26%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.98 | Buy |
| 20-day SMA: | 50.12 | Buy |
| 50-day SMA: | 46.71 | Buy |
| 200-day SMA: | 43.94 | Buy |
| 8-day EMA: | 54.62 | Buy |
| 20-day EMA: | 51.36 | Buy |
| 50-day EMA: | 48.17 | Buy |
| 200-day EMA: | 42.86 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.94 | Buy |
| Relative Strength Index (14 RSI): | 75.11 | Buy |
| Chaikin Money Flow: | 12043 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.35 - 53.49) | Buy |
| Bollinger Bands (100): | (38.6 - 50.9) | Buy |
Protagonist Therapeutics Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 56.37 while PTGX 8-day simple moving average is 54.98, which is a Buy signal.
-
The stock price of PTGX is 56.37 while Protagonist Therapeutics 20-day SMA is 50.12, which makes it a Buy.
-
Protagonist Therapeutics 50-day simple moving average is 46.71 while PTGX share price is 56.37, making it a Buy technically.
-
PTGX stock price is 56.37 and Protagonist Therapeutics 200-day simple moving average is 43.94, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Buy
53
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a BuyThe current Protagonist Therapeutics [PTGX] share price is $56.37. The Score for PTGX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
3.5B
Price in USD:
56.37
Share Volume:
987.5K
Protagonist Therapeutics 52-Week Range
52-Week High:
60.60
52-Week Low:
30.67
Buy
53
Protagonist Therapeutics (PTGX)
is a Buy
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?The Protagonist Therapeutics stock price is 56.37 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is not overvalued.
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 56.37 while PTGX 8-day exponential moving average is 54.62, which is a Buy signal.
-
The stock price of PTGX is 56.37 while Protagonist Therapeutics 20-day EMA is 51.36, which makes it a Buy.
-
Protagonist Therapeutics 50-day exponential moving average is 48.17 while PTGX share price is 56.37, making it a Buy technically.
-
PTGX stock price is 56.37 and Protagonist Therapeutics 200-day simple moving average is 42.86, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.13 per share, a decrease this year of $4.12 per share, and an increase next year of $0.45 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is 2.94, suggesting Protagonist Therapeutics is a Buy
-
Protagonist Therapeutics Relative Strength Index (RSI) is 75.11, which suggest Protagonist Therapeutics is overbought
-
The Bollinger Bands (25) for Protagonist Therapeutics is (44.35 - 53.49), which suggest Protagonist Therapeutics is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics is (38.6 - 50.9), which suggest Protagonist Therapeutics is a Buy
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.